A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents
Keyword(s):
Millions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now several DOACs are available and their use has become more prevalent in recent years. In spite of this increased use, many physicians remain reluctant to prescribe DOACs due to concerns about bleeding and reversibility.
2021 ◽
Vol 77
(18)
◽
pp. 1641
2018 ◽
Vol 24
(1)
◽
pp. 73-82
Keyword(s):
2021 ◽
Vol 77
(18)
◽
pp. 3378
Keyword(s):
2020 ◽
Vol 75
(11)
◽
pp. 271
◽
Keyword(s):
2016 ◽
Vol 67
(13)
◽
pp. 755
Keyword(s):
2018 ◽
Vol 138
(15)
◽
pp. 1519-1529
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 11
(2)
◽
pp. 221-232
◽